Gallagher Carol Giltner
- SEC CIK
- 0001329959
No open-market purchases or sales filed in the past year.
Current role at each company
- PMVP PMV Pharmaceuticals, Inc.Directoras of Jun 5, 2026
- ATRA Atara Biotherapeutics, Inc.Directoras of Jun 12, 2025
- MRTX Mirati Therapeutics, Inc.Directoras of Jan 23, 2024
- FLAC Frazier Lifesciences Acquisition CorpDirectoras of Nov 23, 2022
- TPTX Turning Point Therapeutics, Inc.Directoras of Aug 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gallagher Carol Giltner as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ATRA Atara Biotherapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 (view filing)5:07 PM ET | Nov 13-14 | 2 days | Gallagher Carol GiltnerDirector | PPurchase | +270.0K | $0.2526 | +$68.2K | +142.5%459.4K after | 2 lots |